Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs

Che-Hsin Lee1,2, Cheng-Chia Yu3,4,5, Bing-Yen Wang6,7,8

  • 1Graduate Institute of Basic Medical Science, School of Medicine, China Medical University, Taichung City, Taiwan.

Oncotarget
|November 4, 2015
PubMed

Insights

Cancer stem cells (CSCs) drive tumor growth and recurrence. Tumorsphere assays effectively enrich CSCs and screen for new anti-cancer drugs, offering a promising strategy for future cancer therapeutics.

Area of Science:

  • Oncology
  • Cell Biology
  • Drug Discovery

Background:

  • Cancer stem cells (CSCs) are implicated in tumor initiation, metastasis, drug resistance, and recurrence.
  • Targeting CSCs is crucial for effective cancer treatment strategies.

Purpose of the Study:

  • To highlight the utility of tumorsphere cultivation for CSC analysis and enrichment.
  • To emphasize the role of tumorsphere assays in screening anti-CSC agents and predicting therapeutic efficacy.

Main Methods:

  • Tumorsphere cultivation involves culturing cancer cells in serum-free media on ultralow attachment surfaces with growth factors.
  • This method enriches CSCs and analyzes their self-renewal capabilities.
  • Assays are used to screen for potential anti-CSC agents.

Main Results:

  • Tumorsphere assays provide a reliable platform for identifying and enriching CSCs.
  • In vitro anti-proliferation activity observed in tumorsphere assays correlates better with in vivo anti-tumorigenic activity than monolayer cultures.
  • Tumorsphere assays can evaluate potential anti-cancer agents and inform clinical trial outcomes.

Conclusions:

  • Tumorsphere assays are valuable for studying CSCs and their role in cancer.
  • This method facilitates the screening of novel anti-cancer therapeutics and small-molecule chemicals.
  • Tumorsphere assays represent a promising strategy for developing future cancer treatments.